GlassScriptPhysician profile
Kelli Gaskill
NPI 1427658236
$1,291.13
in general payments reported to CMS, 2019-2025
15 companies · $54.36 in 2025
The $54.36 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $166 · 2022: $623 · 2023: $361 · 2024: $86.46 · 2025: $54.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $501.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $374.19 | 2021-2024 | Caplyta |
| Abbvie INC. | $322.29 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $280.31 | 2021-2025 | Rexulti |
| Neurocrine Biosciences, INC. | $64.33 | 2023-2024 | Ingrezza |
| Lundbeck LLC | $38.90 | 2022-2023 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $36.17 | 2022-2023 | Austedo |
| Takeda Pharmaceuticals U.S.A., INC. | $27.27 | 2023 | Trintellix |
| Janssen Pharmaceuticals, INC | $23.88 | 2022 | |
| Vanda Pharmaceuticals INC. | $20.55 | 2023 | Fanapt, Hetlioz |
| Alkermes, INC. | $19.97 | 2022 | |
| Noven Therapeutics, LLC | $18.39 | 2023 | Xelstrym |
| Axsome Therapeutics, INC. | $18.30 | 2023 | Auvelity |
| Neos Therapeutics, LP | $17.07 | 2024 | Adzenys Xr-Odt |
| Corium, LLC | $15.63 | 2022 | |
| Tris Pharma INC | $13.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Gaskill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.